Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance
From MaRDI portal
Cites work
- Adaptive Two-Stage Designs for Single-Arm Phase IIA Cancer Clinical Trials
- Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes
- Assessing the effect of an influenza vaccine in an encouragement design
- Bayesian inference for causal effects in randomized experiments with noncompliance
- Causal inference in statistics: an overview
- Correcting for non-compliance in randomized trials using structural nested mean models
- Defining and estimating intervention effects for groups that will develop an auxiliary outcome
- Identification and Estimation of Local Average Treatment Effects
- Identification of Causal Effects Using Instrumental Variables
- On the Effect of Treatment among Would-Be Treatment Compliers: An Analysis of the Multiple Risk Factor Intervention Trial
- One-Sample Multiple Testing Procedure for Phase II Clinical Trials
- Practical Bayesian Guidelines for Phase IIB Clinical Trials
- Principal stratification in causal inference
- Principal stratification with predictors of compliance for randomized trials with 2 active treatments
- The potential for bias in principal causal effect estimation when treatment received depends on a key covariate
This page was built for publication: Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6904550)
